baber/WOPTO huggingface dataset:
Patent NZ-563507-A (NZ)
Title: Detector for detecting when an area has been crossed having adjustable detection
Inventor: SCHULTSCHIK DITMAR
IPC: G01J5/00
Filed: 2006-05-08
Abstract: Disclosed is a motion detector comprising of at least one infrared sensor cooperating with an optical device (2) for focusing electromagnetic radiation, and provided with an opening for receiving said electromagnetic radiation. The optical device is connected to the infrared sensor by a rotation guide bearing (5) and is provided with rotation actuating means (6) for actuating rotation in the bearing for the purpose of the precise control of a detection zone and a detection angle. The rotation guide bearing is in the form of two identical half-shells which can be assembled by means of elastically deformable interlocking devices. The half-shells gripping tightly, on the one hand, without any possible rotation, the infrared sensor, and on the other hand, with possible rotation, a guide disc connected to a corresponding end of the optical device.
Patent NZ-568704-A (NZ)
Title: Biologically active compounds derived from Centipeda cunninghamii
Inventor: LEACH DAVID
IPC: A61P29/00
Filed: 2006-11-29
Abstract: Disclosed is the compound of formula II, wherein the substituents are described in the specification. Also disclosed is the use of the compound in the manufacture of a composition for antioxidant or an anti-inflammatory treatment of a human or other mammal.
Patent NZ-574716-A (NZ)
Title: Apparatus and method for visualizing music and other sounds in a circular or helical pattern using coloured lines connecting notes
Inventor: LEMONS KENNETH R
IPC: G09B15/02
Filed: 2007-07-12
Abstract: A computer-implemented method for visualization of music and other sounds comprising the steps of: placing twelve labels corresponding to twelve respective notes (10.1-10.12) in an octave in a circular pattern; identifying the occurrence of a two of the twelve notes; identifying labels corresponding to each of the notes and creating a line (12, 14, 16, 18, 20, 22) connecting the labels. This line is given a colour uniquely corresponding to the interval between the two identified notes. The method can also be extended to multiple octaves by placing the labels along a helix pattern with each turn of the helix containing the twelve labels corresponding to the twelve notes of each octave.
Patent NZ-578673-A (NZ)
Title: Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
Inventor: BEN AYAD OMAR
IPC: A61P9/00
Filed: 2008-02-04
Abstract: Disclosed are azabicycloalkane derivatives of formula (I) or a base, salt, hydrate or solvate thereof, wherein the substituents are disclosed in the specification. Also disclosed is the use of the compounds of formula (I) for the preparation of a medicament for the treatment of neurodegenerative diseases, multiple sclerosis, pain, inflammatory processes, strokes, cerebral hypoxic episodes, prevention of symptoms from weaning from dependence-inducing substances and other diseases as disclosed in the specification.
Patent NZ-580502-A (NZ)
Title: Window frame assembly
Inventor: HALL CHRIS
IPC: E06B1/04
Filed: 2009-10-16
Abstract: A window frame 80 having vertical side jamb sections, a head section and a sill section, with at least one of the side, head and side jamb sections formed from a profiled extrusion. The profiled extrusion terminates in end flanges 5, and comprises at least one spine 2 from which extends at least one fin 9 having a surface which abuts part of the wall structure 82 to which the frame 80 is fitted. The fin 9 includes a formation which receives and retains a trim bead 19 which when connected to the fin 9 provides a finish for the periphery of the frame 80.
Patent NZ-594456-A (NZ)
Title: Compositions and methods for the delivery of nitric oxide
Inventor: CARY STEPHEN P L
IPC: A61K38/42
Filed: 2007-05-21
Abstract: NZ 594456 Disclosed is an isolated H-NOX protein comprising at least one distal pocket mutation wherein the mutation is a replacement of a residue that corresponds to position 74 of Thermoanaerobacter tengcongensis H-NOX by any other amino acid, wherein the mutation alters the NO dissociation constant or NO reactivity compared to that of a corresponding wild-type H-NOX protein.
Patent NZ-594499-A (NZ)
Title: Snood of stiff thread with two strands and loop formed by threading end between two strands
Inventor: PETTERSEN KURT
IPC: A01K91/18
Filed: 2011-08-09
Abstract: A snood is disclosed for use on line/string/tow, where said snood is provided with a loop for attachment to the line/string/tow, where the snood is formed from a stiff snood thread, as the snood is laid with to strands, and where the loop is formed by that an end of the snood is threaded through the two parts in a main body of the snood.
Patent NZ-596864-A (NZ)
Title: Intelligent monitoring camera apparatus and image monitoring system implementing same
Inventor: KIM BAE HOON
IPC: G08B13/196
Filed: 2010-05-26
Abstract: A monitoring camera apparatus and a method for acquiring a monitoring image to be displayed on a remote control apparatus and controlling a centralized monitoring imaging unit installed in a remote site without help of the remote control apparatus is disclosed. The apparatus comprises a storage; a wide-angle imaging unit acquiring a wide-angle image regarding a target area; and a control and signal-processing unit. The control and signal-processing unit detects a location of a moving object from the wide-angle image, controls the centralized monitoring imaging unit to photograph the moving object by generating a control signal corresponding to information on the location of the moving object, receives a centralized monitoring image acquired by the centralized monitoring imaging unit to store in a storage unit, and generates the monitoring image by combining the wide-angle image and the centralized monitoring image to transmit to the remote control apparatus. The storage, the wide-angle imaging unit, and the control and signal-processing unit are housed in a single housing. The storage stores both the wide-angle image and the centralized monitoring image from the centralized monitoring imaging unit and the control and signal-processing unit provides the remote control apparatus with the centralized monitoring image stored in the storage upon request of the remote control apparatus. A remote monitoring system comprises at least one slave camera selectively and intensively photographing a target area and capable of panning/tilting/zooming operation and a master installed in a remote site distant from the slave camera; a remote control apparatus displaying the output Image on a monitor and remotely controlling the master camera. The master camera comprises of a storage, a wide-angle imaging unit for acquiring a wide-angle image regarding a target area, and a control and signal-processing unit installed in a same housing as the wide-angle imaging unit. The control and signal-processing unit detects a location of a moving object from the wide-angle image, drives the slave camera according to the location of the moving object to control the slave camera to photograph the moving object, acquires a centralized monitoring image from the slave camera to store in the storage, and constructs an output image by combining the wide-angle image and the centralized monitoring image. The control and signal-processing unit of the master camera is capable of providing the remote control apparatus with the centralized monitoring image received from the slave camera and stored in the storage unit upon request of the remote control apparatus.
Patent NZ-602820-A (NZ)
Title: Lipid-containing compositions and methods of use thereof
Inventor: BHAGAT URVASHI
IPC: A23L33/00
Filed: 2009-04-20
Abstract: Patent No. 602820 Disclosed is a method of selecting a lipid-containing formulation for administration to a subject, comprising: a) evaluating the subject on the basis of one or more factors selected from: age of the subject, sex of the subject, diet of the subject, the body weight of the subject, physical activity level of the subject, lipid tolerance of the subject, medical conditions of the subject, family medical history of the subject, and ambient temperature range of the subject’s living area, and b) combining daily amounts of fatty acids comprising omega-6 and omega-3 fatty acids, wherein the ratio of omega-6 to omega-3 fatty acids and/or their amounts are controlled based on the one or more factors; wherein the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 4:1 or greater; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 10:1 if the subject has a diet of low antioxidants and/or low phytochemicals; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 4:1 to 45:1 if the subject has a diet of high antioxidants and/or high phytochemicals; or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 2:1 to 30:1 if the subject has a diet of high seafood; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 45:1 based on lipid tolerance of the subject; and/or the formulation provides a dosage of omega-6 and omega-3 at an omega-6 to omega-3 ratio of 1:1 to 50:1 if the subject has a condition wherein gradual increase of omega-6 and/or gradual withdrawal of omega-3 is necessary.
Patent NZ-623495-A (NZ)
Title: Oral formulations of cytidine analogs and methods of use thereof
Inventor: BACKSTROM JAY THOMAS
IPC: A61K31/7068
Filed: 2009-05-14
Abstract: Disclosed is a pharmaceutical composition for oral administration comprising a therapeutically effective amount of 5-azacytidine, wherein the composition releases the 5-azacytidine substantially in the stomach following oral administration to a subject. The composition is useful in the treatment of a disease associated with abnormal cell proliferation such as myelodysplastic syndrome or acute myelogenous leukaemia.
Patent NZ-626738-A (NZ)
Title: Motor flushing system
Inventor: MAXWELL GREGORY WAYNE
IPC: B63H21/38
Filed: 2012-11-28
Abstract: Disclosed is a marine flushing apparatus for an inboard motor, generator set or air conditioning unit of an aquatic vessel. The apparatus includes a fresh water holding tank with a level indicator on board the vessel. At least one flushing pump is included for each motor or generator set associated with the fresh water holding tank. The apparatus also includes a solenoid valve located between the at least one flushing pump of the motor or generator set and a raw water feed. A controller is included to check at actuation, the level of fresh water in the fresh water holding tank and to abort startup of a flushing sequence if the level is insufficient and to actuate a flushing sequence if the level is sufficient wherein. When the level is sufficient, the controller insures that the solenoid valve these energized after actuation of the at least one flushing pump to ensure that the raw water feed is replaced by fresh water from the fresh water holding tank without substantial interruption.
Patent NZ-630260-A (NZ)
Title: Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
Inventor: ITO NOBUAKI
IPC: C07D409/12
Filed: 2013-04-23
Abstract: Disclosed herein is the dihydrate of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one (brexpiprazole) or of a salt thereof, and a process for producing the same. The dihydrate is intended for use in pharmaceutical compositions, particularly for intramuscular injection to achieve more effective therapeutic treatment of central nervous system diseases including schizophrenia, psychotic disorder, mood disorder, bipolar disorder, mania, depression, anxiety disorder, somatoform disorder, factitious disorder, dissociative disorder, sexual disorder, eating disorder, sleep disorder, substance-related disorder, delirium, cognitive impairment, cognitive impairment associated with Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative diseases, vomiting, motion sickness, obesity, migraine, pain, mental retardation, autism, Tourette’s syndrome, tic disorder, attention deficit hyperactivity disorder, conduct disorder, and Down’s syndrome.
Patent NZ-715354-A (NZ)
Title: Injection device
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2014-06-11
Abstract: An injection device for delivering an injection comprises a housing having a longitudinal axis, a proximal end and a distal end, the housing being arranged such that the injection is delivered from its distal end; and a release mechanism comprising an impediment, the release mechanism being moveable between a first position, in which the impediment is in an impeding position so as to impede the delivery of the injection, and a second position, in which the impediment is in a non-impeding position so as to not impede the delivery of the injection, wherein the force required to move the release mechanism from the first position to the second position varies with the distance moved by the release mechanism, the variation in the force required with distance being represented by a force profile, which is non-linear.
Patent NZ-717658-A (NZ)
Title: Automated screening of enzyme variants
Inventor: SARMIENTO RUSSELL JAVINIAR
IPC: G16B35/00
Filed: 2014-09-26
Abstract: Disclosed are methods for identifying bio-molecules with desired properties (or which are most suitable for a round of directed evolution) from complex bio-molecule libraries or sets of such libraries. Some embodiments of the present disclosure provide methods for virtually screening proteins for beneficial properties. Some embodiments of the present disclosure provide methods for virtually screening enzymes for desired activity and/or selectivity for catalytic reactions involving particular substrates. Some embodiments combine screening and directed evolution to design and develop proteins and enzymes having desired properties. Systems and computer program products implementing the methods are also provided.
Patent NZ-726302-A (NZ)
Title: Fitting for use with armored cable
Inventor: RIVEST DEAN W
IPC: H01R13/52
Filed: 2015-06-01
Abstract: A fitting for use with a cable (12) contained in a corrugated metal tubing (14), comprising an adaptor (100) having a longitudinal passage to receive the cable; a body (200) coupled to the adaptor, including a body sealing surface; an internal seal (400) disposed radially about the cable, and positioned between the adaptor and the body; a nut (300) coupled to the body; and a sealing member (600) positioned between the nut and the body. The sealing member includes a sealing surface configured to be placed in a valley of the corrugated metal tubing to compress a peak of the corrugated metal tubing between the sealing surface of the sealing member and the body sealing surface of the body such that the compressed peak forms a metal-to-metal seal. The invention provides an alternative sealing means at a junction point of an armored cable in hazardous environments.
Patent NZ-737004-A (NZ)
Title: Triazole agonists of the apj receptor
Inventor: KALLER MATTHEW
IPC: C07D413/04
Filed: 2016-05-18
Abstract: Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures where the definitions of the variables are provided herein.
Patent NZ-738566-A (NZ)
Title: Method for cleaning indoor unit and outdoor unit of air conditioner
Inventor: MINGJIE ZHANG
IPC: F25B47/02
Filed: 2016-12-02
Abstract: The present invention discloses a method for cleaning an air conditioner indoor unit and outdoor unit. The method includes: controlling a to-be-cleaned heat exchanger to enter a self-cleaning mode; adjusting an operating frequency of an air conditioner, an opening of a throttling device, and a corresponding fan speed of the to-be-cleaned heat exchanger, and maintaining an evaporating temperature of the working fluid in the to-be-cleaned heat exchanger within a present range, so as to enable a surface of the to-be-cleaned heat exchanger to frost; keeping the to-be-cleaned heat exchanger frosting for a time of t1; detecting whether a differential pressure between a high pressure and a low pressure of the working fluid in air conditioner meets a preset condition; when the differential pressure between the high pressure and the low pressure of the working fluid in the air conditioner meets the preset condition, controlling a four-way valve to change a direction, so as to perform a defrosting switching to indoor and outdoor heat exchangers; and when the differential pressure between the high pressure and the low pressure of working fluid in the air conditioner does not meet the preset condition, adjusting an operating parameter of the air conditioner to enable the differential pressure between the high pressure and the low pressure of working fluid in the air conditioner to meet the preset condition, and then controlling the four-way valve to change the direction, so as to perform a defrosting switching to the indoor and outdoor heat exchangers. A direction change of the four-way valve may be controlled by detecting whether the differential pressure between the high pressure and the low pressure of working fluid in the air conditioner meets the preset condition. Therefore, a great shock to the compressor because of an excessive differential pressure between the high pressure and the low pressure of working fluid in the air conditioner may be avoided.
Patent NZ-739052-A (NZ)
Title: An injector
Inventor: SMITH ROBIN
IPC: A61M5/46
Filed: 2016-08-26
Abstract: Current castration methods cause concern on animal welfare grounds as a degree of pain is experienced by the animal during the castration process. This pain could be minimised by using anaesthetic, however anaesthetic is not typically provided as it is difficult to administer. The invention solves this problem by providing an injector having a two stage injection that allows for anaesthetised castration procedures to be efficiently performed. The injector comprises: an outer housing having a first end and a second end; and a plunger assembly for being received within the outer housing and comprising a barrel having a needle disposed at an end thereof and a plunger for dispensing a fluid through the needle; in use the plunger assembly being movable within the outer housing between a retracted position wherein the needle is at least partially housed within the outer housing and an engaged position wherein the needle projects outwardly of a needle opening located at the first end of the outer housing and whereby a rotary inhibiting mechanism interacts with the plunger assembly to inhibit movement of the plunger within the barrel until the plunger assembly has reached the engaged position.
Patent NZ-743651-A (NZ)
Title: Benzothiophene-based selective estrogen receptor downregulators
Inventor: THATCHER GREGORY
IPC: A61K31/381
Filed: 2016-12-09
Abstract: This invention is benzothiophene-based estrogen receptor downregulators and their compositions and uses to treat estrogen-related medical disorders.
Patent NZ-744036-A (NZ)
Title: Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
Inventor: CHIN MELANIE PEI-HENG
IPC: A61P13/12
Filed: 2014-08-22
Abstract: Provided are methods for treating and preventing endothelial dysfunction and related disorders using bardoxolone methyl or analogs thereof (see formula (I)). In a preferred embodiment bardoxolone methyl or a pharmaceutically acceptable salt or tautomer thereof is used in the manufacture of a medicament for treating chronic kidney disease (CKD) or renal disease in a patient, wherein the patient’s estimated glomerular filtration rate (eGFR) is greater than or equal to 30 mL/min/1.73 m2 and: (a) the patient has been identified as not having a history of left-sided myocardial disease; (b) the patient has been identified as not having an elevated B-type natriuretic peptide (BNP) level; or (c) the patient has been identified as not having an elevated albumin/creatinine ratio (ACR). This reduces the likelihood of a cardiovascular event during treatment.
Patent NZ-744327-A (NZ)
Title: Optical pickup assembly having optical pickup units laterally arranged across a data medium storage path
Inventor: WILSON SCOTT
IPC: G11B7/14
Filed: 2014-01-30
Abstract: Space is limited for arranging multiple optical pickup units (OPUs) in optical data storage systems. An optical data storage system includes optical pickup assemblies that each include optical pickup units (OPUs) that have respective objective lenses for transmitting and receiving light to and from an optical data storage medium. The OPUs of each optical pickup assembly are arranged laterally across a data storage medium path and are positioned at roughly a same longitudinal position along the data storage medium path. The respective objective lenses of the OPUs are laterally offset from each other across the data storage medium path.
Patent NZ-745267-A (NZ)
Title: Novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n- methylmethanamine
Inventor: KIM AERI
IPC: C07D207/48
Filed: 2017-03-17
Abstract: The present invention provides a novel acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine, wherein the acid is succinic acid, tartaric acid, or fumaric acid. The above-described acid addition salt can have not only excellent proton pump inhibitory activity, gastric damage inhibitory activity and defensive factor-enhancing effect, but also excellent eradication activity against H. pylori and thus can be effectively used for the prevention and treatment of gastrointestinal injury due to gastrointestinal track ulcer, gastritis, reflux esophagitis, or H. pylori.
Patent NZ-754196-A (NZ)
Title: Pharmaceutical formulations of a hif hydroxylase inhibitor
Inventor: CONCA DAVID
IPC: A61K9/28
Filed: 2014-06-05
Abstract: The present disclosure relates to pharmaceutical formulations of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid in the preparation of medicaments for the treatment, pretreatment, or delay of onset or progression of a condition mediated at least in part by hypoxia inducible factor (HIF) and anemia. The formulation comprises a coating comprising titanium dioxide and a dye which stabilises [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid from light-induced degradation.
Patent PT-102186-A (PT)
Title: Network terminator for wide band networks
Inventor: QUESADA JUAN IGNACIO SOLANA DE
IPC: H04B10/08
Filed: 1998-08-03
Abstract: The network terminator for wide band networks is comprised of a single-mode electrooptical access converter 1, an HDS access terminator 4, a synchronisation module 2, a single-mode or multimode electrooptical user converter 3, an HDS user terminator 5 and a process module 6, there also being an interface 7 for connection to the network of the operator, an interface 8 for connection to the user network and an interface 9 for connection to an outside PC 16. The equipment, in addition to optical regeneration and single- mode/multimode conversion, makes it possible to construct real-time testing and verification circuits for the quality of service in the user layer, making it possible to delimit the responsibilities in both zones of responsibility, user and operator. <IMAGE>